查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594358

口腔炎治療藥物市場：按藥物類別、配方和最終用戶分類 - 全球預測 2025-2030

Mouth Ulcers Treatment Market by Drug Class (Analgesics, Antihistamine, Antimicrobial), Formulation (Gels & Ointments, Mouthwash, Sprays), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

口腔炎治療藥物市場2023年估值為12.3億美元，預計到2024年將達到13億美元，複合年成長率為5.26%，預計到2030年將達到17.7億美元。

口腔潰瘍治療市場包括旨在減輕口腔潰瘍（口瘡性潰瘍）症狀和促進癒合的產品和治療方法，口腔潰瘍是一種在口腔中發生的疼痛性潰瘍。這些治療的需求源於口腔潰瘍的流行，由於壓力、營養缺乏和某些健康狀況等因素，口腔潰瘍影響了很大一部分人口。口腔潰瘍的治療用途包括非處方凝膠、乳霜、清洗和處方藥，目的是即時緩解症狀並促進癒合。最終使用領域包括醫院、牙科診所和居家照護場所，反映了從專業牙科治療到自我護理解決方案的廣泛消費群體。推動市場成長要素包括口腔健康意識的提高、藥物配方的進步以及對即時緩解解決方案不斷成長的需求。天然和草本治療方法的開發蘊藏著新的商機，反映出消費者對有機產品日益成長的偏好。此外，都市化進程的加速和生活方式的改變正在推動人們對預防性醫療保健的關注，為企業提供創新預防性醫療保健解決方案的機會。然而，市場成長受到對產品功效的擔憂、潛在副作用和新興市場定價壓力等因素的阻礙。此外，發展中地區認知度低也是阻礙因素。在應用奈米技術進行藥物持續釋放和使用生物技術進行標靶治療都有創新。將人工智慧更好地融入預測建模和個人化治療計劃的研究代表了業務成長的前沿。專注於最大限度地減少副作用和最大限度地提高藥物傳輸有效性的研究將改善治療結果。隨著現有製藥公司和新參與企業尋求生物友好且具有成本效益的解決方案，市場競爭仍在繼續，需要建立策略聯盟來維持市場地位並利用新機會和持續創新的重要性。

主要市場統計
基準年[2023] 12.3億美元
預測年份 [2024] 13億美元
預測年份 [2030] 17.7億美元
複合年成長率（%） 5.26%

市場動態：快速發展的口腔炎治療市場的關鍵市場洞察

供需的動態交互作用正在改變口腔潰瘍藥物市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 世界人口中口腔炎的盛行率很高
    • 用於治療口腔潰瘍的商業產品的可用性
    • 越來越重視以病人為中心的口腔潰瘍治療計劃
  • 市場限制因素
    • 現有口腔炎治療方法效果有限
  • 市場機會
    • 介紹一種新的、更有效的口腔潰瘍治療方法
    • 醫療保健支出不斷增加，人們更加關注口腔健康
  • 市場挑戰
    • 與口腔潰瘍相關的某些副作用

波特五力：駕馭口腔炎藥物市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解口腔炎治療藥物市場的外部影響

外部宏觀環境因素在塑造口腔炎治療藥物市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解口腔炎治療藥物市場的競爭狀況

口腔炎治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質口腔炎治療市場供應商表現評估

FPNV定位矩陣是評估口腔炎治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪口腔炎治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，口腔炎治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界人口中口腔潰瘍的盛行率很高
      • 治療口腔炎的非處方藥的可用性
      • 口腔炎治療計劃增加了以病人為中心的護理的重要性
    • 抑制因素
      • 現有的口腔炎治療方法效果有限
    • 機會
      • 介紹一種新的、更有效的口腔潰瘍治療方法
      • 醫療保健成本不斷上升，人們對口腔健康的興趣日益濃厚
    • 任務
      • 與口腔潰瘍相關的某些副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依藥物類別分類的口腔炎治療藥物市場

  • 止痛藥
  • 抗組織胺藥
  • 抗菌的
  • 皮質類固醇

第7章 處方口腔炎治療藥物市場

  • 凝膠和軟膏
  • 漱口水
  • 噴

第8章口腔炎治療藥物市場：依最終使用者分類

  • 牙醫診所
  • 醫院

第9章北美及南美口腔炎治療藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太口腔炎治療藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲口腔炎治療藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Apotex Inc.
  • Blairex Laboratories Inc
  • Blistex Inc.
  • Bristol-Myers Squibb Company
  • Church & Dwight, Inc.
  • Colgate-Palmolive Company
  • Dr. Reddy's Laboratories Ltd
  • EPIEN Medical Inc.
  • GlaxoSmithKline PLC
  • Guilin Sanjin Pharmaceutical Co Ltd
  • ICPA Health Products Ltd.
  • Intas Pharmaceuticals Ltd.
  • LloydsPharmacy Limited
  • Meta Tubex Private Limited
  • Patterson Dental Supply, Inc.
  • Pfizer Inc.
  • Prince Care Pharma Private Limited
  • Raptakos Brett & Company Limited
  • Reckitt Benckiser Group PLC
  • Sinclair Pharma Ltd.
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd
  • Sunstar Suisse SA
  • Taro Pharmaceutical Industries Ltd.
Product Code: MRR-2A0283E25685

The Mouth Ulcers Treatment Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 5.26%, to USD 1.77 billion by 2030.

The scope of the mouth ulcers treatment market encompasses the products and therapies aimed at alleviating the symptoms and promoting healing of mouth ulcers, or aphthous ulcers, which are painful sores that occur in the oral cavity. The necessity for these treatments arises from the prevalence of mouth ulcers, which affect a significant portion of the population due to causes like stress, nutritional deficiencies, and certain health conditions. Applications of mouth ulcer treatments include over-the-counter gels, creams, rinses, and prescribed medications, targeting immediate relief and accelerated healing. End-use segments involve hospitals, dental clinics, and home care settings, reflecting a broad consumer base from professional dental care to self-care solutions. Key growth factors driving the market include increasing awareness about oral health, advancements in pharmaceutical formulations, and the rising demand for quick-relief solutions. Emerging opportunities lie in the development of natural or herbal-based treatments, reflecting growing consumer preference for organic products. Furthermore, increasing urbanization and lifestyle changes are encouraging preventive care focus, presenting opportunities for companies to innovate preventive care solutions. However, market growth is challenged by factors like product efficacy concerns, potential side effects, and pricing pressures in emerging markets. Additionally, the lack of awareness in developing regions acts as a constraint. Innovations are seen in nanotechnology applications for sustained drug release and the use of biotechnology for targeted therapies. Greater integration of artificial intelligence in research for predictive modeling and personalized treatment plans represents a frontier for business growth. Research focused on minimizing side-effects and maximizing drug delivery efficacy is poised to improve treatment outcomes. The market remains competitive with established pharmaceutical companies and new entrants exploring bio-friendly and cost-effective solutions, emphasizing the importance of strategic alliances and continuous innovation to maintain market presence and leverage new opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.30 billion
Forecast Year [2030] USD 1.77 billion
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mouth Ulcers Treatment Market

The Mouth Ulcers Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of mouth ulcers among global population
    • Availability of over-the-counter products for mouth ulcer treatment
    • Growing emphasis on patient-centric care mouth ulcer treatment plans
  • Market Restraints
    • Limited efficacy of existing treatments for mouth ulcers
  • Market Opportunities
    • Introduction of new and more effective mouth ulcer treatments
    • Rising healthcare expenditure and increased focus on oral health
  • Market Challenges
    • Certain side effects associated with mouth ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Mouth Ulcers Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mouth Ulcers Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mouth Ulcers Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mouth Ulcers Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mouth Ulcers Treatment Market

A detailed market share analysis in the Mouth Ulcers Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mouth Ulcers Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mouth Ulcers Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mouth Ulcers Treatment Market

A strategic analysis of the Mouth Ulcers Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mouth Ulcers Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Inc., Blairex Laboratories Inc, Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight, Inc., Colgate- Palmolive Company, Dr. Reddy's Laboratories Ltd, EPIEN Medical Inc., GlaxoSmithKline PLC, Guilin Sanjin Pharmaceutical Co Ltd, ICPA Health Products Ltd., Intas Pharmaceuticals Ltd., LloydsPharmacy Limited, Meta Tubex Private Limited, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, Raptakos Brett & Company Limited, Reckitt Benckiser Group PLC, Sinclair Pharma Ltd., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd, Sunstar Suisse S.A, and Taro Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Mouth Ulcers Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across Analgesics, Antihistamine, Antimicrobial, and Corticosteroids.
  • Based on Formulation, market is studied across Gels & Ointments, Mouthwash, and Sprays.
  • Based on End-User, market is studied across Dental Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of mouth ulcers among global population
      • 5.1.1.2. Availability of over-the-counter products for mouth ulcer treatment
      • 5.1.1.3. Growing emphasis on patient-centric care mouth ulcer treatment plans
    • 5.1.2. Restraints
      • 5.1.2.1. Limited efficacy of existing treatments for mouth ulcers
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new and more effective mouth ulcer treatments
      • 5.1.3.2. Rising healthcare expenditure and increased focus on oral health
    • 5.1.4. Challenges
      • 5.1.4.1. Certain side effects associated with mouth ulcers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mouth Ulcers Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Analgesics
  • 6.3. Antihistamine
  • 6.4. Antimicrobial
  • 6.5. Corticosteroids

7. Mouth Ulcers Treatment Market, by Formulation

  • 7.1. Introduction
  • 7.2. Gels & Ointments
  • 7.3. Mouthwash
  • 7.4. Sprays

8. Mouth Ulcers Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dental Clinics
  • 8.3. Hospitals

9. Americas Mouth Ulcers Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Mouth Ulcers Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Mouth Ulcers Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Apotex Inc.
  • 3. Blairex Laboratories Inc
  • 4. Blistex Inc.
  • 5. Bristol-Myers Squibb Company
  • 6. Church & Dwight, Inc.
  • 7. Colgate- Palmolive Company
  • 8. Dr. Reddy's Laboratories Ltd
  • 9. EPIEN Medical Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Guilin Sanjin Pharmaceutical Co Ltd
  • 12. ICPA Health Products Ltd.
  • 13. Intas Pharmaceuticals Ltd.
  • 14. LloydsPharmacy Limited
  • 15. Meta Tubex Private Limited
  • 16. Patterson Dental Supply, Inc.
  • 17. Pfizer Inc.
  • 18. Prince Care Pharma Private Limited
  • 19. Raptakos Brett & Company Limited
  • 20. Reckitt Benckiser Group PLC
  • 21. Sinclair Pharma Ltd.
  • 22. STADA Arzneimittel AG
  • 23. Sun Pharmaceutical Industries Ltd
  • 24. Sunstar Suisse S.A
  • 25. Taro Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. MOUTH ULCERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MOUTH ULCERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOUTH ULCERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOUTH ULCERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023